Copyright: ©Author(s) 2026.
World J Stem Cells. Sep 26, 2026; 18(9): 125409
Published online Sep 26, 2026. doi: 10.4252/wjsc.125409
Published online Sep 26, 2026. doi: 10.4252/wjsc.125409
Figure 3 Proposed framework for lung organoids in combination therapy and safety assessment.
This figure presents a conceptual model for how lung organoids may be applied to evaluate combination and key safety domains. EV: Extracellular vesicle; MSC: Mesenchymal stromal cell.
- Citation: Yang LY, Xing YF, Chen JY, Cao ZM, Ye H. Lung organoids for preclinical evaluation of stem cell therapies: Opportunities, evidence, and translational challenges. World J Stem Cells 2026; 18(9): 125409
- URL: https://www.wjgnet.com/1948-0210/full/v18/i9/125409.htm
- DOI: https://dx.doi.org/10.4252/wjsc.125409